Entry |
|
Name |
Nemtabrutinib (USAN/INN) |
Formula |
C25H23ClN4O4
|
Exact mass |
478.1408
|
Mol weight |
478.92
|
Structure |

|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG02022 BTK inhibitor
|
Efficacy |
Antineoplastic, Bruton's tyrosine kinase inhibitor |
Target |
|
Pathway |
hsa04662 | B cell receptor signaling pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG02022 BTK inhibitor
D12504 Nemtabrutinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Non-receptor tyrosine kinases
TEC family
BTK
D12504 Nemtabrutinib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 34
1 C8x C 14.7755 -13.1637
2 N5x N 14.7755 -14.5643
3 C8y C 15.9884 -15.2646
4 C8y C 17.2014 -14.5643
5 C8y C 17.2014 -13.1637
6 N5x N 15.9884 -12.4635
7 C8y C 18.5334 -14.9971
8 C8x C 19.3566 -13.8640
9 N4x N 18.5334 -12.7310
10 C5a C 18.9647 -16.3244
11 C8y C 20.3652 -16.3244
12 O5a O 18.1503 -17.4455
13 C8x C 21.0646 -17.5356
14 C8x C 22.4652 -17.5356
15 C8y C 23.1655 -16.3226
16 C8x C 22.4661 -15.1114
17 C8y C 21.0655 -15.1114
18 O2a O 24.5794 -16.3227
19 C8y C 25.2831 -15.1040
20 C8x C 26.6802 -15.1041
21 C8x C 27.3806 -13.8913
22 C8x C 26.6804 -12.6783
23 C8x C 25.2833 -12.6781
24 C8x C 24.5829 -13.8910
25 X Cl 20.3740 -13.9137
26 N1b N 15.9884 -16.6650
27 C1y C 14.7587 -17.3751
28 C1x C 13.5542 -16.6798
29 O2x O 12.3413 -17.3800
30 C1y C 12.3414 -18.7806
31 C1x C 13.5458 -19.4760
32 C1x C 14.7587 -18.7757
33 C1b C 11.1223 -19.4846
34 O1a O 9.9103 -18.7850
BOND 38
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 1
11 7 10 1
12 10 11 1
13 10 12 2
14 11 13 2
15 13 14 1
16 14 15 2
17 15 16 1
18 16 17 2
19 11 17 1
20 15 18 1
21 18 19 1
22 19 20 2
23 20 21 1
24 21 22 2
25 22 23 1
26 23 24 2
27 19 24 1
28 17 25 1
29 3 26 1
30 27 26 1 #Down
31 27 28 1
32 28 29 1
33 29 30 1
34 30 31 1
35 31 32 1
36 27 32 1
37 30 33 1 #Up
38 33 34 1
|